Does anyone know if insurance continues to cover semaglutide once the diabetes diagnosis is removed? That's my concern — I'm in a similar trajectory and worried about losing coverage.
Does anyone know if insurance continues to cover semaglutide once the diabetes diagnosis is removed?
This varies hugely by plan. Some will switch the indication to obesity management (BMI-based), some require a new prior auth, and some will drop coverage entirely. It's worth having a proactive conversation with your endo about coding strategy before the diagnosis is officially changed. Some docs will keep "insulin resistance" or "pre-diabetes" as a code even after A1C normalizes, which can preserve coverage.
Good point about insurance. My endo is keeping me coded as "obesity, BMI 31.5" which is still accurate and is a covered indication on my plan. She was very thoughtful about the timing. The T2D history code is also documented which helps with prior auths.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsFor those who like numbers, here's what the research says about this kind of trajectory:
The STEP 2 trial showed an average A1C reduction of 1.6 percentage points on semaglutide 2.4mg in patients with T2D. An A1C drop of 3.8 points (9.2 to 5.4) is well above average, which suggests diet/exercise modifications played a significant complementary role. The weight loss of 66 lbs (~25%) is also above the trial average of ~10%, further supporting that lifestyle changes amplified the pharmacological effect.
Great result. The data backs up the approach.